Outcomes in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis

被引：0
|
作者：
Cottin, Vincent [1 ]
Spagnolo, Paolo [2 ]
Bonniaud, Philippe [3 ]
Nolin, Maeva [4 ]
Dalon, Faustine [4 ]
Chia, Jenny [5 ]
Kirchgassler, Klaus [6 ]
Kamath, Tripthi [5 ]
Van Ganse, Eric [4 ]
Belhassen, Manon [4 ]
机构：
[1] Univ Claude Bernard Lyon 1, Univ Lyon, Hosp Civils Lyon,Louis Pradel Hosp,UMR754,ERN LUN, Natl Reference Coordinating Ctr Rare Pulm Dis,IVP, Lyon, France
[2] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Resp Dis Unit, Padua, Italy
[3] Univ Bourgogne Franche Comte, Ctr Hosp Univ Bourgogne, Ctr Reference Constitutif Malad Pulm Rares Adulte, Serv Pneumol & Soins Intensifs Resp,Fac Med & Pha, Dijon, France
[4] PELyon, Lyon, France
[5] Genentech Inc, San Francisco, CA 94080 USA
[6] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4091
引用
收藏
页码：121 / 121
页数：1
相关论文
共 50 条
  • [1] Outcomes in Patients Receiving Nintedanib or Pirfenidone for Idiopathic Pulmonary Fibrosis
    Cottin, V.
    Spagnolo, P.
    Bonniaud, P.
    Nolin, M.
    Dalon, F.
    Kirchgassler, K.
    Chia, J.
    Kamath, T. V.
    Van Ganse, E.
    Belhassen, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [2] Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Belhassen, Manon
    Dalon, Faustine
    Nolin, Maeva
    Van Ganse, Eric
    [J]. RESPIRATORY RESEARCH, 2021, 22 (01)
  • [3] Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Manon Belhassen
    Faustine Dalon
    Maëva Nolin
    Eric Van Ganse
    [J]. Respiratory Research, 22
  • [4] Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis
    Sathiyamoorthy, Gayathri
    Sehgal, Sameep
    Ashton, Rendell W.
    [J]. SOUTHERN MEDICAL JOURNAL, 2017, 110 (06) : 393 - 398
  • [5] SAFETY OF COMBINED PIRFENIDONE AND NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Flaherty, K. R.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    [J]. THORAX, 2017, 72 : A253 - A254
  • [6] Healthcare resource use and related costs in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis
    Bonniaud, Philippe
    Cottin, Vincent
    Spagnolo, Paolo
    Nolin, Maeva
    Dalon, Faustine
    Kirchgassler, Klaus-Uwe
    Chia, Jenny
    Kamath, Tripthi
    Van Ganse, Eric
    Belhassen, Manon
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [7] Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Cottin, Vincent
    Spagnolo, Paolo
    Bonniaud, Philippe
    Dalond, Faustine
    Nolind, Maeva
    Kirchgassler, Klaus-Uwe
    Van Ganse, Eric
    Belhassen, Manon
    [J]. RESPIRATORY MEDICINE AND RESEARCH, 2023, 83
  • [8] Comparative Effectiveness of Nintedanib and Pirfenidone in Patients Diagnosed With Idiopathic Pulmonary Fibrosis
    Shankar, D.
    Law, A.
    Walkey, A. J.
    Hawkins, F. J.
    Alysandratos, K.
    Wilson, K. C.
    Bosch, N. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis
    Dempsey, Timothy M.
    Payne, Stephanie
    Sangaralingham, Lindsey
    Yao, Xiaoxi
    Shah, Nilay D.
    Limper, Andrew H.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1121 - 1128
  • [10] Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
    Ogura, Takashi
    Taniguchi, Hiroyuki
    Azuma, Arata
    Inoue, Yoshikazu
    Kondoh, Yasuhiro
    Hasegawa, Yoshinori
    Bando, Masashi
    Abe, Shinji
    Mochizuki, Yoshiro
    Chida, Kingo
    Klueglich, Matthias
    Fujimoto, Tsuyoshi
    Okazaki, Kotaro
    Tadayasu, Yusuke
    Sakamoto, Wataru
    Sugiyama, Yukihiko
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1382 - 1392
12345